p53 proteasomal degradation: Poly-ubiquitination is not the whole story

Cell Cycle

Volumn 4, Issue 8, 2005, Pages 1015-1018

  Asher, Gad ^a   Shaul, Yosef ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

20S and 26S proteasomes; Dicoumarol; NADH; NQO1; p53; p73; Protein degradation; Ubiquitination; irradiation

Indexed keywords

ALPHA SYNUCLEIN; PROTEIN MDM2; PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

APOPTOSIS; CANCER CELL CULTURE; DISSOCIATION; DNA DAMAGE; GAMMA IRRADIATION; GENETIC POLYMORPHISM; HUMAN; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEIN SYNTHESIS REGULATION; SHORT SURVEY; TUMOR SUPPRESSOR GENE; UBIQUITINATION; ULTRAVIOLET IRRADIATION; VIRUS ONCOGENE;

EID: 25444445785     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.4.8.1900     Document Type: Short Survey

References (47)

1. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67:425-79.
2. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol Rev 2002; 82:373-428.
3. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10.
4. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387:299-303.
5. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387:296-9.
6. Shmueli A, Oren M. Regulation of p53 by Mdm2: Fate is in the numbers. Mol Cell 2004; 13:4-5.
7. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R, Benchimol S. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 2003; 112:779-91.
8. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 2004; 429:86-92.
9. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63:1129-36.
10. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993; 75:495-505.
11. Asher G, Lotem J, Cohen B, Sachs L, Shaul Y. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci USA 2001; 98:1188-93.
12. Asher G, Lotem J, Kama R, Sachs L, Shaul Y. NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci USA 2002; 99:3099-104.
13. Asher G, Lotem J, Sachs L, Kahana C, Shaul Y. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci USA 2002; 99:13125-30.
14. Asher G, Lotem J, Tsvetkov P, Reiss V, Sachs L, Shaul Y. P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H: Quinone oxidoreductase 1. Proc Natl Acad Sci USA 2003; 100:15065-70.
15. Asher G, Lotem J, Sachs L, Shaul Y. p53-dependent apoptosis and NAD(P)H: Quinone oxidoreductase 1. Methods Enzymol 2004; 382:278-93.
16. Asher G, Tsvetkov P, Kahana C, Shaul Y. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev 2005; 19:316-21.
17. Anwar A, Dehn D, Siegel D, Kepa JK, Tang LJ, Pietenpol JA, Ross D. Interaction of human NAD(P)H: Quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. J Biol Chem 2003; 278:10368-73.
18. Long IInd DJ, Gaikwad A, Multani A, Pathak S, Montgomery CA, Gonzalez FJ, Jaiswal AK. Disruption of the NAD(P)H: Quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia. Cancer Res 2002; 62:3030-6.
19. Long IInd DJ, Waikel RL, Wang XJ, Roop DR, Jaiswal AK. NAD(P)H: Quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a] -anthracene-induced carcinogenesis in mouse skin. J Natl Cancer Inst 2001; 93:1166-70.
20. Iskander K, Gaikwad A, Paquet M, Long IIndDJ, Brayton C, Barrios R, Jaiswal AK. Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis. Cancer Res 2005; 65:2054-8.
21. Jaiswal AK. Regulation of genes encoding NAD(P)H: Quinone oxidoreductases. Free Radic Biol Med 2000; 29:254-62.
22. Tsvetkov P, Asher G, Reiss V, Shaul Y, Sachs L, Lotem J. Inhibition of NAD(P)H: Quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci USA 2005; 102:5535-40.
23. McLure KG, Takagi M, Kastan MB. NAD+ modulates p53 DNA binding specificity and function. Mol Cell Biol 2004; 24:9958-67.
24. Soussi T. The p53 tumor suppressor gene: From molecular biology to clinical investigation. Ann NY Acad Sci 2000; 910:121-37, (discussion 137-9).
25. Tada M, Yokosuka O, Fukai K, Chiba T, Imazeki F, Tokuhisa T, Saisho H. Hypermethylation of NAD(P)H: Quinone oxidoreductase 1 (NQO1) gene in human hepatocellular carcinoma. J Hepatol 2005; 42:511-9.
26. Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, Ross D. Characterization of a polymorphism in NAD(P)H: Quinone oxidoreductase (DT-diaphorase). Br J Cancer 1997; 75:69-75.
27. Siegel D, Anwar A, Winski SL, Kepa JK, Zolman KL, Ross D. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H: Quinone oxidoreductase 1. Mol Pharmacol 2001; 59:203-8.
28. Ross D, Siegel D. NAD(P)H: Quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol 2004; 382:115-44.
29. Brooks P, Fuertes G, Murray RZ, Bose S, Knecht E, Rechsteiner MC, Hendil KB, Tanaka K, Dyson J, Rivett J. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem J 2000; 346:155-61.
30. David DC, Layfield R, Serpell L, Narain Y, Goedert M, Spillantini MG. Proteasomal degradation of tau protein. J Neurochem 2002; 83:176-85.
31. Tofaris GK, Layfield R, Spillantini MG. Alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett 2001; 509:22-6.
32. Orlowski M, Wilk S. Ubiquitin-independent proteolytic functions of the proteasome. Arch Biochem Biophys 2003; 415:1-5.
33. Nioi P, Hayes JD. Contribution of NAD(P)H: Quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat Res 2004; 555:149-71.
34. Anderson SP, Howroyd P, Liu J, Qian X, Bahnemann R, Swanson C, Kwak MK, Kensler TW, Corton JC. The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes. J Biol Chem 2004; 279:52390-8.
35. Rossi M, De Laurenzi V, Munariz E, Green DR, Liu YC, Vousden KH, Cesareni G, Melino G. The ubiquitin-protein ligase Itch regulates p73 stability. Embo J 2005; 24:836-48.
36. Bloom J, Pagano M. To be or not to be ubiquitinated? Cell Cycle 2004; 3:138-40.
37. Sheaff RJ, Singer JD, Swanger J, Smitherman M, Roberts JM, Clurman BE. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell 2000; 5:403-10.
38. Fotedar R, Bendjennat M, Fotedar A. Role of p21WAF1 in the cellular response to UV. Cell Cycle 2004; 3:134-7.
39. Touitou R, Richardson J, Bose S, Nakanishi M, Rivett J, Allday MJ. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J 2001; 20:2367-75.
40. Coleman ML, Marshall CJ, Olson MF. Ras promotes p21 (Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J 2003; 22:2036-46.
41. Bloom J, Amador V, Bartolini F, DeMartino G, Pagano M. Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell 2003; 115:71-82.
42. Bossis G, Ferrara P, Acquaviva C, Jariel-Encontre I, Piechaczyk M. c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo. Mol Cell Biol 2003; 23:7425-36.
43. Coffino P. Regulation of cellular polyamines by antizyme. Nat Rev Mol Cell Biol 2001; 2:188-94.
44. Verma R, Deshaies RJ. A proteasome howdunit: The case of the missing signal. Cell 2000; 101:341-4.
45. Asher G, Bercovich Z, Tsvetkov P, Shaul Y, Kahana C. 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1. Mol Cell 2005; 17:645-55.
46. Liu CW, Corboy MJ, DeMartino GN, Thomas PJ. Endoproteolytic activity of the proteasome. Science 2003; 299:408-11.
47. Dyson HJ, Wright PE. Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 2005; 6:197-208.